1. Jundt JS, Gutta R. Characteristics and cost impact of severe odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:558-66.

https://doi.org/10.1016/j.oooo.2011.10.044

PMid:22819453 

2. Uluibau IC, Jaunay T, Goss AN. Severe odontogenic infections. Aust Dent J. 2005;50:S74-81.

https://doi.org/10.1111/j.1834-7819.2005.tb00390.x

PMid:16416722 

3. Flynn TR, Shanti RM, Hayes C. Severe odontogenic infections, part 2: prospective outcomes study. J Oral Maxillofac Surg. 2006;64:1104-13.

https://doi.org/10.1016/j.joms.2006.03.031

PMid:16781344 

4. Opitz D, Camerer C, Camerer DM, Raguse JD, Menneking H, Hoffmeister B, et al. Incidence and management of severe odontogenic infections-A retrospective analysis from 2004 to 2011. J Cranio-Maxillofac Surg. 2015;43:285-9.

https://doi.org/10.1016/j.jcms.2014.12.002

PMid:25555896 

5. Sainuddin S, Hague R, Howson K, Clark S. New admission scoring criteria for patients with odontogenic infections: a pilot study. Br J Oral Maxillofac Surg. 2017;55:86-89

https://doi.org/10.1016/j.bjoms.2016.05.003

PMid:27238201 

6. Seppänen L, Lauhio A, Lindqvist C, Suuronen R, Rautemaa R. Analysis of systemic and local odontogenic infection complications requiring hospital care. J Infect. 2008;57:116-22.

https://doi.org/10.1016/j.jinf.2008.06.002

PMid:18649947 

7. Kaplan HB, Edelson HS, Korchak HM, Given WP, Abramson S, Weissmann G. Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo. Biochem Pharmacol. 1984;33:371-8.

https://doi.org/10.1016/0006-2952(84)90228-4

Pmid:6422946

8. Giagoudakis G, Markantonis SL. Relationships between the concentrations of prostaglandins and the nonsteroidal antiinflammatory drugs indomethacin, diclofenac, and ibuprofen. Pharmacotherapy. 2005;25:18-25.

https://doi.org/10.1592/phco.25.1.18.55618

PMid:15767216 

9. Mathieu D, Neviere R, Teillon C, Chagnon JL, Lebleu N, Wattel F. Cervical necrotizing fasciitis: clinical manifestations and management. Clin Infect Dis. 1995;21:51-6.

https://doi.org/10.1093/clinids/21.1.51

PMid:7578759 

10. Solberg CO, Allred CD, Hill HR. Influence of phenylbutazone on leukocyte chemiluminescence and function. Acta Pathol Microbiol Scand. 1978;86C:165-71.

https://doi.org/10.1111/j.1699-0463.1978.tb02575.x

PMid:358750 

11. Brun-Buisson CJ, Saada M, Trunet P, Rapin M, Roujeau JC, Revuz J. Haemolytic streptococcal gangrene and non-steroidal anti-inflammatory drugs. Br Med J Clin Res Ed.1985;290:1786.

https://doi.org/10.1136/bmj.290.6484.1786

PMid:3924256 PMCid:PMC1415937

12. Aronoff DM, Bloch KC. Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus. Medicine. 2003;82:225-35.

https://doi.org/10.1097/01.md.0000085060.63483.bb

PMid:12861100 

13. Eter EG, Khazzaka A, Mneimneh W, Karam-Sarkis D, Haddad A, Sarkis R. Does diclofenac increase the risk of cervical necrotizing fasciitis in a rat model?. Int J Exp Pathol. 2009;90:58-65.

https://doi.org/10.1111/j.1365-2613.2008.00594.x

PMid:19200252 PMCid:PMC2669610

14. Weng TC, Chen CC, Toh HS, Tang HJ. Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice. J Microbiol Immunol Infect. 2011;44:418-23.

https://doi.org/10.1016/j.jmii.2011.04.012

PMid:21697021 

15. Bennani-Baïti AA, Benbouzid A, Essakalli-Hossyni L. Cervicofacial cellulitis: The impact of non-steroidal anti-inflammatory drugs. A study of 70 cases. Eur Ann Otorhinolaryngol Head Neck Dis. 2015;132:181-4.

https://doi.org/10.1016/j.anorl.2015.06.004

PMid:26139417 

16. Bali RK, Sharma P, Gaba S, Kaur A, Ghanghas P. A review of complications of odontogenic infections. Natl J Maxillofac Surg. 2015;6:136-43.

https://doi.org/10.4103/0975-5950.183867

PMid:27390486 PMCid:PMC4922222

17. French Health Products Safety Agency (Afssaps). Prescribing antibiotics in odontology and stomatology. Recommendations by the French Health Products Safety Agency. Fundam Clin Pharmacol. 2003;17:725-9.

https://doi.org/10.1046/j.0767-3981.2003.00205.x

PMid:15015718 

18. Jundt JS, Gutta R. Characteristics and cost impact of severe odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:558-66.

https://doi.org/10.1016/j.oooo.2011.10.044

PMid:22819453 

19. Flynn TR, Shanti RM, Levi MH, Adamo AK, Kraut RA, Trieger N. Severe odontogenic infections, part 1: prospective report. J Oral Maxillofac Surg. 2006;64:1093-103.

https://doi.org/10.1016/j.joms.2006.03.015

PMid:16781343 

20. Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome?. Clin Infect Dis. 1995;21:977-80.

https://doi.org/10.1093/clinids/21.4.977

PMid:8645850 

21. Stevens DL, Bryant AE. Necrotizing Soft-Tissue Infections. N Engl J Med. 2017;377:2253-65.

https://doi.org/10.1056/NEJMra1600673

PMid:29211672 

22. Hamilton SM, Bayer CR, Stevens DL, Bryant AE. Effects of selective and nonselective nonsteroidal anti-inflammatory drugs on antibiotic efficacy of experimental group A streptococcal myonecrosis. J Infect Dis. 2014;209:1429-35.

https://doi.org/10.1093/infdis/jit594

PMid:24218498 PMCid:PMC3982845